GxP, already configured.

Every blueprint is the same platform, configured: controlled records, review, change control, training, audit evidence. Not modules to buy. Starting points neil tailors to your process.

119/119

Systems

18
mes

Batch records that guide the run.

Seal captures the batch as it runs. AI-configured workflows evolve with your process. Unified with LIMS, QMS, and ELN.

qms

Quality events with execution context.

Every quality event arrives with full context. AI-configured workflows evolve with your process. Unified with MES, LIMS, and ELN.

lims

Results checked against the specs they serve.

Seal checks results against live specs. AI-configured methods evolve with your process. Unified with MES, QMS, and ELN.

eln

Experiments that become execution evidence.

Seal turns experiments into structured evidence. AI-configured methods evolve with your process. Unified with LIMS, MES, and QMS.

inventory

Know exactly what material you have—and whether it can be used now.

Control every material definition, lot, container, quantity, location, status, expiry, storage exposure, reservation, movement, dispense, use, reconciliation, and disposition—from receipt to batch genealogy.

clinical

Run trials, not reconciliations.

EDC, CTMS, and eTMF share one data model. Sites enter data once. Documents file themselves. Queries resolve in context.

equipment

The sticker is not the control—the current qualified state and point-of-use decision are.

Asset identity, hierarchy, intended use, criticality, qualification, calibration, cleaning, status, usage, logbooks, configuration, maintenance coordination, operator eligibility, impact assessment, change, and retirement.

dms

One effective instruction. Every copy, training impact, and approval accounted for.

Controlled authoring, review, approval, effective dates, distribution, training impact, periodic review, forms, external documents, archival, and point-of-use access for GxP records.

ctms

The operational truth of the trial—from country plan to site closeout.

Study, country and site planning; feasibility; startup; activation; enrollment; monitoring; issues; payments; vendors; milestones; closeout; and sponsor oversight connected to EDC, eTMF, safety, and quality.

rims

The approved product, in every market, with every obligation still visible.

Products, registrations, dossiers, submissions, health-authority correspondence, commitments, labeling, regulatory intelligence, and market-specific change assessments in one global regulatory record.

plm

Bench to BLA. One recipe.

For sponsors and CDMOs alike: recipe-driven development, one-click tech transfer, MSAT continuity, and CMC submissions rendered from the live spine. The line, the master batch record, and Module 3 say the same thing because they're views of the same object.

lms

Know who may perform the work—not merely who opened the document.

Role curricula, document-triggered training, practical assessment, qualification, requalification, equivalency, trainer authorization, effectiveness, and work authorization in one GxP learning record.

cmms

From observed condition to safe return to service—with the production and quality impact attached.

Maintenance requests, criticality, preventive and meter-based plans, work permits, lockout, work orders, parts, contractors, calibration coordination, breakdowns, production impact, return to service, reliability, and recurring-failure improvement.

wms

Every lot has a permitted state, place, movement, and use.

GMP receiving, quarantine, put-away, status and location control, sampling moves, FEFO allocation, picking, kitting, dispensing handoff, cold chain, cycle count, shipping, returns, and recall traceability.

etmf

Expected evidence to filed artifact. Completeness, timeliness, quality, provenance, inspection, and archive in one trial record.

Plan and manage trial-master-file content using governed reference models and study-specific expectations; ingest, classify, QC, approve and file artifacts; track completeness, timeliness and quality by study, country and site; manage correspondence, access, inspection packages, transfer, reconciliation, and long-term archive.

edc

Protocol to eCRF. Entry to query. Clean patient data to a controlled database lock.

Design and validate clinical studies, eCRFs and edit checks; manage subjects, visits and site entry; ingest external data; run medical and data review; govern queries, coding and reconciliation; track cleaning; freeze and lock the database; and deliver traceable analysis-ready datasets.

sdms

Instrument output to immutable evidence. Capture, context, review, search, retention, and restore without losing provenance.

Automatically capture scientific instrument and application data, preserve original files and metadata, prove file-set completeness and integrity, connect data to samples and work, govern review and derived versions, search across formats, retain and restore records, and manage migrations and legal holds.

SM

Collection to container. Parent to aliquot. Freezer position to final use. Every sample remains identifiable and accountable.

Plan collections, create labels and containers, maintain chain of custody, model rooms and storage positions, manage aliquoting, pooling and derivatives, reserve and request samples, pick and ship with verification, track tests and consumption, monitor excursions, reconcile discrepancies, and govern retention and disposition.

Workflows

75
TT

Transfer the process, not the paperwork.

Seal transfers the process as data. AI-configured workflows evolve with your process. Unified with MES, QMS, and ELN.

EBR

Electronic batch records. Execution, not paper on a screen.

Author, execute, review, and release GMP batch records with material and equipment checks, automated data capture, controlled exceptions, and complete history.

PD

Turn experimental runs into a process definition that can mature, scale, characterize, and transfer.

Product and process targets, unit operations, materials, experiments, parameters, scale models, yields, samples, quality attributes, knowledge claims, process candidates, maturity gates, and transfer readiness connected across ELN, LIMS, equipment, characterization, and tech transfer.

PV

From first awareness to a valid case, jurisdiction-specific report, assessed signal, and accountable risk action.

Safety intake, minimum criteria, triage, duplicate search, follow-up, MedDRA and product coding, seriousness, expectedness, causality, case quality, jurisdiction-aware timelines, ICSR generation and acknowledgements, aggregate reporting, signals, benefit-risk, and safety-quality linkage.

APR

A signed conclusion with every number, rule, and source still attached.

Controlled report definitions, governed metrics, frozen data cuts, traceable tables and narratives, review, approval, scheduling, distribution, and live quality intelligence across GxP operations.

EM

The monitoring plan, actual operation, sample, organism, trend, excursion, and batch impact on one timeline.

Risk-based viable, nonviable, surface, personnel and utility monitoring with governed locations, schedules, production context, chain of custody, incubation, counts, identification, limits, trend rules, excursions, investigations, product impact, and program review.

eDHR

eDHR. Every unit carries its manufacturing proof.

Execute the device master record with component genealogy, in-process inspection, UDI and labels, sterilization, nonconformance, and release attached to every lot or serial number.

Supplier

Supplier to site. Site to material and service. Qualification, agreements, lots, changes, performance, SCARs, and current approval connected.

Manage supplier, manufacturer and site identities; risk and material or service scope; qualification plans, questionnaires and audits; quality agreements; approved-supplier states; incoming lot and CoA performance; deviations, complaints and SCARs; supplier changes; scorecards, monitoring, requalification, restrictions, and disqualification.

BR

Every release requirement resolved to evidence. Every decision preserved in context.

Plan batch-release evidence from the approved product state, review execution and testing concurrently, resolve exceptions, control market eligibility, generate CoAs, and sign an accountable disposition.

CTS

Clinical supply. Blinded, available, accountable.

Protocol demand, kit and label design, packaging, randomization identifiers, depot and site inventory, temperature, returns, and reconciliation.

Cleaning

Cleaning validation. Limits, execution, samples, and equipment state in one control loop.

Connect product and equipment matrices, residue limits, worst-case rationale, cleaning instructions, swab and rinse samples, deviations, and continued verification.

eLog

Electronic logbooks. Facility memory that controls the next action.

Replace paper equipment, area, utility, and shift logs with structured GMP entries, live status, task handoffs, exception workflows, and traceable review.

OOS / OOT

OOS and OOT investigations. Follow the evidence before choosing the cause.

Run laboratory assessment, hypothesis testing, manufacturing investigation, batch impact, CAPA, trending, and disposition without losing the original result or scientific rationale.

Data Integrity

Data integrity. Review the event in the work that gave it meaning.

Define the regulated record universe, schedule risk-based audit trail review, reconstruct changes in context, investigate anomalous activity, and prove that every GxP decision used complete and trustworthy evidence.

PV

Approved process to executable protocol. PPQ evidence to continued verification. Every claim traceable to source.

Plan and execute process performance qualification, govern readiness and acceptance criteria, connect manufacturing and laboratory evidence, resolve deviations, calculate capability, approve validation conclusions, and hand the proven process into continued verification.

Risk

Hazard, sequence of events, harm, estimate, control, verification, residual risk, and real-world evidence connected.

Medical-device ISO 14971 risk files and pharmaceutical quality risk management with plans, hazard analyses, FMEAs, risk criteria, control options, verification, residual and overall risk, benefit-risk, production and post-production evidence, review, and change impact.

Micro LIMS

Microbiology LIMS. Every plate, organism, location, and batch in context.

Run environmental monitoring, sterility, bioburden, endotoxin, utilities, growth promotion, incubation, organism identification, excursions, trending, and release.

CQV

Commissioning and qualification. Every requirement proved by the right test.

Plan and execute facility, utility, equipment, automation, and computerized-system CQV from requirements and risk through turnover, testing, exceptions, release, and continued qualified state.

APS / Media Fill

Media fills. Prove the challenged process is the process you actually run.

Design APS coverage across lines, shifts, operators, interventions, container configurations, campaign conditions, incubation, unit reconciliation, failures, and requalification.

Specifications

Specifications. The right limits, methods, market, material, and effective date—together.

Control material, in-process, release, and stability specifications across products, sites, markets, methods, sampling plans, lifecycle stages, changes, testing, and disposition.

cmc

Every CMC claim tied to its source, approved state, and submission history.

Connect product definitions, processes, specifications, methods, characterization, validation, stability, claims, CTD sections, market variants, review, and post-approval change without rebuilding truth in documents.

Reg

A quality change is not complete until every affected market can use it.

Connect QMS changes, health-authority commitments, market assessments, submission dependencies, implementation controls, and closure evidence without turning the QMS into a second RIMS.

APQR

APQR and PQR. A governed product review, not a year-end spreadsheet project.

Continuously assemble batches, results, deviations, changes, stability, complaints, supplier evidence, process capability, conclusions, and follow-up actions.

Methods

Analytical methods. From intended purpose to routine performance.

Connect analytical target profiles, development knowledge, validation characteristics, transfer protocols, method versions, instruments, specifications, and routine monitoring.

CCS

Contamination control strategy. Every risk linked to a working control and current evidence.

Build and maintain a living CCS across facility, people, utilities, cleaning, sterilization, aseptic process, monitoring, investigations, trends, changes, and sterility assurance review.

Packaging

Packaging operations. The right bulk, components, artwork, code, count, and market on one line.

Control packaging orders, line readiness, components and printed materials, coding, in-process checks, rejects, rework, label reconciliation, aggregation, yields, deviations, and packaged-batch release.

Clean Utilities

Clean utilities. Know the qualified state, every point of use, and every batch exposed.

Operate PW, WFI, clean steam, process gas, vacuum, and other high-risk utilities with system topology, qualification, online monitoring, point-of-use sampling, sanitization, maintenance, trends, excursions, and product impact.

CPV

Continued process verification. Know when the process is changing—and why.

Monitor version-aware process parameters, material attributes, equipment, yields, holds, deviations, and quality attributes with governed populations, signals, and actions.

Calibration

Calibration and metrology. Know what each measurement can be trusted to decide.

Control instrument ranges, procedures, reference standards, due work, as-found and as-left data, uncertainty, tolerances, out-of-tolerance impact, labels, and use eligibility.

Standards & Reagents

Laboratory materials. The right value, container, clock, preparation, and use behind every result.

Qualify standards and critical reagents, prepare controlled solutions, enforce container and open-life state, record exact analytical use, and find every result affected by a later material concern.

Partner Quality

Quality agreements. Turn written responsibilities into routed work, evidence, and accountable decisions.

Make sponsor, CDMO, laboratory, supplier, packaging, storage, and distribution responsibilities executable across notifications, investigations, record exchange, release, escalation, performance, and review.

Sterilization

Sterilization loads. Every item, position, cycle parameter, indicator, exception, and use controlled.

Manage moist and dry heat, depyrogenation, gas, radiation, and other sterilization processes with validated load patterns, item genealogy, cycle recipes, probes, indicators, physical records, exceptions, load release, and downstream impact.

Recall

Recalls and market actions. Find the exact population, reach every consignee, prove effectiveness.

Run health-hazard evaluation, affected-lot and unit scope, recall strategy, authority communication, consignee notification, response tracking, product reconciliation, effectiveness checks, status reporting, and termination.

Cold Chain

Cold chain. Every handoff, temperature, exposed unit, and disposition in one record.

Qualify routes and shipping systems, assemble logger evidence, calculate exact exposure, identify the affected physical population, and make stability-backed disposition decisions without reconstructing a journey from emails.

training

Signed off. Can't run the method.

Competency enforced at point of work. AI-configured curricula per role. Unified with QMS, MES, and LIMS.

Serialization

Serialization. Every saleable unit, case, pallet, and event reconciled.

Connect packaging orders, serial numbers, UDI or product identifiers, commissioning, aggregation, labels, exceptions, EPCIS exchange, warehouse events, verification, and recall.

Raw Materials

Raw materials. Every container controlled before the first weighment.

Connect supplier qualification, purchase and shipment data, container receipt, quarantine, sampling plans, identity and specification testing, status labels, expiry, release, and manufacturing eligibility.

CSV / CSA

Intended use. Critical functions. Enough evidence for every release.

Control regulated-system inventory, intended use, function risk, supplier evidence, right-sized testing, releases, changes, and periodic review without turning validation into a document factory.

labeling

The label said Sample A.

Labels generated from live records, not retyped into Bartender. Every scan linked. Unified with MES, LIMS, and Inventory.

Visual Inspection

Every inspected unit. Every defect decision. One reconciled population.

Govern manual and automated visual inspection, defect libraries, inspector qualification, challenge sets, reject genealogy, investigations, reconciliation, trending, and finished-batch disposition.

msat

Development intent to manufacturing reality. Every signal, investigation, change, and transfer strengthens the process model.

Run Manufacturing Science and Technology across process ownership, technology transfer, site and product knowledge, batch monitoring, process signals, investigations, change impact, validation and CPV, improvement, comparability, commitments, and governed manufacturing support.

Cell Banks

Source to vial. Vial to culture. Every generation authorized and traceable.

Control master and working cell banks, viral and microbial seed lots, strains, characterization, cryogenic locations, vial withdrawal, passage, suitability, and downstream manufacturing impact.

AD

From analytical target profile to a transferable, controlled method—with the learning intact.

Analytical target profiles, experiments, method parameters, chromatographic and spectral evidence, forced degradation, robustness, control strategy, validation readiness, transfer, and lifecycle knowledge connected to ELN, SDMS, LIMS, instruments, and standards.

CoA

The released result, specification, statement, template, signature, and delivered certificate stay the same record.

Source-approved results, specification versions, reportable-value rules, batch and material identity, template applicability, statements, multilingual rendering, review, signature, issue, amendment, supersession, portal delivery, API data, and acknowledgement.

W&D

The $400,000 mistake.

Barcode verification blocks wrong materials. Balance data direct, no transcription. Unified with MES, LIMS, and Inventory.

Single-Use

Design to connection. Every component lot and product-contact path proven.

Control single-use assembly designs, supplier components, sterilization, extractables and leachables, build and installation, connections, integrity tests, use windows, product contact, and disposition.

PC

Risk question to designed study. Experimental result to proven range. Every control-strategy decision retains its evidence.

Manage process characterization strategy, prior knowledge, risk assessments, DoE and edge-of-failure studies, parameter-to-quality relationships, scale and platform models, proven ranges, design-space claims, control-strategy decisions, and validation handoff.

ChemSafe

Know the substance, container, place, hazard, exposure, and waste path now.

Chemical approval, inventory, SDS versions, GHS labels, storage compatibility, quantity limits, risk assessment, exposure controls, inspections, incidents, hazardous waste, emergency inventory, and jurisdiction-aware reporting.

Cleanroom Cleaning

Every surface covered. Every contact time proven. Every room released deliberately.

Plan and execute cleanroom cleaning and disinfection by area and surface, control agent preparation and rotation, prove coverage and contact time, assess missed work, verify effectiveness, and govern return to use.

PAT / RTRT

Process signal to quality prediction. Prediction to an authorized release decision.

Govern PAT methods, sensors, chemometric models, calibration sets, predictions, process actions, model lifecycle, RTRT strategies, fallback testing, and batch-release evidence.

UD

Cell source to seed train. Feed strategy to harvest. Every run teaches the process that follows.

Run cell-culture and fermentation development with governed cell lineage, media and feed versions, executable recipes, connected bioreactors, samples and assays, clone and process comparisons, scale-up models, perfusion state, harvest decisions, characterization, and technology transfer.

PACMP

One technical change. Every market pathway, commitment, and implementation condition resolved.

Assess post-approval CMC changes across products and markets, govern established conditions and PACMPs, assemble comparability evidence, track authority outcomes, and prevent premature implementation.

DD

Harvest pool to purified bulk. Every fraction, membrane, column cycle, hold, and scale decision remains connected.

Run purification and formulation development with governed harvest inputs, buffers and solutions, chromatography and filtration methods, column and membrane lifecycle, fractions and pools, samples and assays, yield and clearance balances, holds, scale-up models, characterization, and technology transfer.

Stability

Protocol, batch, condition, chamber, inventory, pull, test, trend, shelf-life evidence, excursion, and commitment connected.

ICH-aligned and custom stability protocols, batches, packaging configurations, chambers, sample inventory, pull windows, chain of custody, testing, trends, statistical analyses, excursions, OOS and OOT, shelf-life proposals, commitments, annual placement, reports, and archive.

Controlled

Every gram authorized. Every movement balanced. Every discrepancy investigated.

Control DEA registrations, schedules and authority, receipts, vault inventory, manufacturing issues and yields, transfers, returns, waste, destruction, physical inventories, reconciliation, and loss reporting.

RS

Plan the application, govern every content claim and source, publish the package, and retain exactly what was sent.

Submission strategy, content plans, dossiers, source data, authoring, claims, references, reviews, translations, eCTD lifecycle, technical validation, dispatch, acknowledgements, health-authority questions, commitments, and approved-state updates.

Lyophilization

Filled vial to dried cake. Every load position, phase transition, alarm, and release decision connected.

Govern lyophilization recipes, product and load configurations, loading and stoppering, chamber readiness, source cycle data, endpoints, exceptions, unload genealogy, quality results, validation, and release.

AR

Know what was asked, what scope applies, what evidence answers it, and exactly what was shared.

Inspection preparation, readiness assessments, front- and back-room request control, scoped evidence packages, point-in-time verification, secure review, response approval, commitments, observations, metrics, and continuous remediation across GxP systems.

Docs

Author, challenge, approve, implement, distribute, review, and retire without losing the effective state.

The governed workflow for document requests, authorship, review, approval, change impact, training, effective dates, controlled copies, periodic review, supersession, and archival—composed with DMS, training, change control, and validation.

Supplier Change

One external change. Every material, process, batch, study, filing, and market consequence resolved before use.

Receive supplier change notifications, establish affected supplied items and lots, calculate where-used impact, plan evidence, respond to the supplier, govern inventory transition, and authorize implementation by product and market.

Deviation

Event to containment. Evidence to cause. Product impact to effective action. No ‘human error’ dead ends.

Capture manufacturing, laboratory, facility, equipment and data deviations with live context; control containment and notifications; classify and scope impact; plan and execute evidence-based investigations; test hypotheses and recurrence; approve root cause and product decisions; connect CAPAs and changes; verify effectiveness; trend systemic signals; and close with complete rationale.

CCIT

Package configuration to leak path. Method capability to shelf-life claim. Every integrity conclusion traceable.

Govern container-closure configurations, critical quality attributes, CCIT methods, positive controls and standards, validation, routine and stability studies, transport challenges, results, investigations, trending, and lifecycle decisions.

CAPA

The CAPA that never actually worked.

Effectiveness verification as a gate, not a checkbox. AI-drafted CAPA plans from similar historical events. Unified with QMS and MES.

E&L

Every product-contact material, exposure condition, analytical signal, compound identity, and toxicological conclusion connected to actual use.

Map product-contact systems, characterize materials, plan extractables and leachables studies, calculate exposure and analytical evaluation thresholds, identify compounds, govern toxicological assessments, justify bracketing, and manage lifecycle change.

Change

Approved isn't finished.

CC-2024-047 was approved in January. Six months later, the procedure still showed the old process. Implementation tracking that ensures changes actually happen.

Sterile Filtration

Filter design to installed assembly. PUPSIT to post-use integrity. Every product population and exception bounded.

Govern sterilizing filtration strategies, filter and assembly configurations, bacterial-retention and product-specific validation, sterilization and installation, PUPSIT and post-use integrity testing, process parameters, interventions, failures, and batch disposition.

Nitrosamines

Molecular risk to formation pathway. Acceptable intake to batch result. Mitigation to market implementation.

Govern product and API nitrosamine risk assessments, amine and nitrosating-agent knowledge, formation pathways, acceptable-intake limits, confirmatory methods and testing, mitigation, stability, supplier dependencies, regulatory reporting, and lifecycle review.

Aseptic Qualification

Training is not authorization. Every person, cleanroom grade, intervention, observation, monitoring result, and current permission connected.

Govern aseptic roles, curricula, gowning qualifications, practical assessments, APS participation, intervention authorization, cleanroom access, personnel monitoring, observations, restrictions, requalification, and live execution eligibility.

Complaint

One intake. Every issue, clock, investigation, and patient-safety handoff accounted for.

Capture product complaints across channels, preserve awareness, separate quality and safety assessments, investigate with lot and return evidence, report under governed rules, trend signals, and close the customer loop.

Viral Safety

Source risk, adventitious-agent evidence, clearance mechanism, study run, log-reduction claim, and commercial process state connected.

Govern biologics viral safety strategies, source and cell-substrate risk, virus testing, adventitious-agent methods, scaled-down clearance models, spiking studies, log-reduction calculations, step and process claims, lifecycle changes, and batch-release dependencies.

NC

Contain the item, understand the requirement, and govern what may happen next.

Material, component, product and process nonconformances with immediate segregation, affected-population trace, evaluation, MRB review, rework, repair, return, scrap, concession, execution, effectiveness, supplier linkage, and trending.

Design

Gaps found before audits. Not after.

The traceability matrix showed Input → Output → Verification for every requirement except one. Class I recall followed. Live traceability that exposes gaps before auditors do.

Compendial Change

Publication change to affected monograph. Monograph to every material, method, specification, product, filing, and implementation deadline.

Monitor USP, Ph. Eur., JP and other compendial changes, compare requirements, calculate product and market impact, evaluate methods and specifications, plan laboratory and regulatory evidence, govern dual-state implementation, and prove timely compliance.

Validation

Three hours hunting a binder.

Qualification history, calibration, and verification in one record. AI-drafted IQ/OQ/PQ protocols. Unified with Equipment and QMS.

Audit

Program to plan. Evidence to finding. Response to verified commitment. Every audit remains accountable after the closing meeting.

Plan risk-based internal, supplier and regulatory audit programs; qualify auditors; prepare scope and evidence; execute agendas, interviews and sampling; govern observations and findings; coordinate responses, CAPAs and commitments; verify effectiveness; trend themes; manage inspection rooms; and close with a complete record.

Industries

26
Pharma

Pharmaceutical manufacturing. One operating record from receipt to release.

Connect materials, electronic batch records, QC, equipment, quality events, labels, stability, and release without rebuilding the batch across systems.

Greenfield

Open the facility digitally. Not on paper.

The operating architecture, master data, validation, cutover, and receipt-to-release proving path for a new GMP manufacturing site.

Sterile

Aseptic manufacturing. One continuous state of control.

Connect sterile compounding and fill-finish, contamination control, environmental monitoring, interventions, qualification, microbiology, and release.

Pharma QC

Pharmaceutical QC. The lab shouldn't hold the batch.

Samples, instruments, specifications, OOS, stability, environmental monitoring, and CoA generation in one GMP laboratory flow.

cgt

Batch of one. Patient of one.

Every cell knows its patient. AI-configured for autologous and allogeneic. Unified with LIMS, MES, and QMS.

Biologics

Biopharma manufacturing. The batch starts at the bank.

Cell-bank genealogy, upstream execution, downstream pools, single-use assemblies, process analytics, viral safety, and release in one commercial record.

MedDev

Req 47? One click.

ISO 13485, EU MDR, FDA 21 CFR 820. Design controls through post-market surveillance. When the auditor asks to see requirement 47, you click once.

biotech

Skip the GMP wall.

R&D flexibility. GMP compliance. No migration.

cdmo

You sell capacity. You deliver trust.

Per-client data isolation without vendor consultants. AI-configured Blueprints per client. Unified with MES, LIMS, and QMS.

503B

Pharmacy tools can't make drugs.

Pharmaceutical-grade batch records and EM trending. AI-configured for 503B workflows. Unified with LIMS and QMS.

Vaccines

Vaccine manufacturing. Every lot release-ready.

Seed and antigen genealogy, formulation, filling, potency and sterility testing, cold chain, release protocols, and regulator-facing lot evidence.

Radiopharma

Radiopharmacy operations. Release before the dose disappears.

Decay-aware production, synthesis and cassette genealogy, rapid QC, patient-dose dispensing, transport, equipment state, and post-release evidence.

OSD

Oral solid dose. Every gram reconciled.

Material genealogy and electronic batch execution from dispensing through granulation, compression, coating, packaging, and release.

Combo

Combination products. One release across two quality systems.

Drug or biologic genealogy joined to device configuration, assembly, essential performance, design change, complaints, and final release.

API

API manufacturing. Every transformation traceable.

Electronic batch execution and genealogy across raw materials, reactions, intermediates, equipment, process testing, quality, and release.

Viral Vector

Viral vector manufacturing. Plasmids, cells, capsids, genomes, and doses—one lineage.

Run AAV, lentiviral, and other viral-vector production with plasmid and bank genealogy, transfection, harvest, purification, potency, vector safety, fill, cryostorage, and release.

Peptides

Peptide manufacturing. Every residue, coupling, fraction, pool, and impurity in one lineage.

Run solid- and liquid-phase peptide synthesis, fragment condensation, cleavage, deprotection, purification fractions, pooling, conjugation, counterion exchange, drying, analytical control, mass balance, and release.

biobanking

The sample was there. The consent wasn't.

Consent travels with the sample. Provenance for every aliquot. Unified with ELN, LIMS, and QMS.

Allogeneic

Allogeneic cell therapy. One donor lineage, many controlled doses.

Connect donor eligibility, starting material, master and working cell banks, engineering, expansion, harvest, formulation, dose lots, potency, cryostorage, allocation, and patient impact.

Contract Lab

Contract laboratory LIMS. One sample operation, many client boundaries.

Run quotes, client methods and specifications, sample accessioning, chain of custody, capacity, testing, OOS, QA review, COAs, portals, retain storage, and billing.

Oligo

Oligonucleotide manufacturing. The sequence drives every cycle, fraction, and pool.

Run phosphoramidite synthesis, cycle-level material control, cleavage and deprotection, purification fractions, pooling, conjugation, duplexing, ultrafiltration, lyophilization, analytical testing, and release.

Cell Therapy

Cell therapy manufacturing. One patient, one chain of identity, one accountable journey.

Orchestrate treatment orders, collection, chain of identity and custody, patient-specific manufacturing, QC, cryogenic storage, release, logistics, and treatment-center handoffs.

mRNA

mRNA manufacturing. Sequence, template, process, lipid, and vial stay connected.

Connect DNA template, in-vitro transcription, purification, lipid nanoparticle formulation, sterile fill, analytical data, cold chain, deviations, and lot release.

ADC

ADC manufacturing. Antibody, linker-payload, conjugation, and containment in one genealogy.

Connect antibody and linker-payload supply, potent-compound control, conjugation, purification, DAR analytics, material balance, cleaning, fill finish, partner handoffs, and release.

Continuous

Material moves through time. Every disturbance, residence window, control action, diversion, collection, and batch boundary reconstructed.

Operate continuous drug-substance and drug-product processes with time-based material genealogy, residence-time distributions, process-state classification, PAT and active controls, disturbance management, diversion, collection, batch definition, review, validation, and release.

Inhalation

Formulation and device are one delivered-dose system. Every material attribute, component lot, assembly state, aerosol test, and release decision connected.

Run metered-dose inhaler, dry-powder inhaler, nebulized solution and suspension manufacturing with formulation and device configuration, component genealogy, filling and assembly, conditioning, delivered-dose and aerodynamic testing, stability, investigations, and release.

Don't see your process? Blueprints are outputs, not a product list. neil configures yours from your own procedures.